EAST LANSING, MICHIGAN / ACCESSWIRE / February 20, 2025 / Teach Access, a national nonprofit bridging the accessible technology skills gap is thrilled to announ ...
Four new SPMS patients not eligible for a Tiziana Life Sciences trial were dosed with foralumab nasal spray in an expanded access program.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback